Global Non-invasive Cancer Diagnosis Market Size, Status and Forecast 2019-2025

1 Report Overview

• 1.1 Study Scope
• 1.2 Key Market Segments
• 1.3 Players Covered: Ranking by Non-invasive Cancer Diagnosis Revenue
• 1.4 Market by Type
  • 1.4.1 Global Non-invasive Cancer Diagnosis Market Size Growth Rate by Type: 2020 VS 2026
  • 1.4.2 Clinical Chemistry
  • 1.4.3 Immunochemistry/Immunoassay
  • 1.4.4 Molecular Diagnostics
  • 1.4.5 Others
• 1.5 Market by Application
  • 1.5.1 Global Non-invasive Cancer Diagnosis Market Share by Application: 2020 VS 2026
  • 1.5.2 Blood Cancer
  • 1.5.3 Solid Tumors
  • 1.5.4 Breast Cancer
  • 1.5.5 Lung Cancer
  • 1.5.6 Others
• 1.6 Study Objectives
• 1.7 Years Considered

2 Global Growth Trends

• 2.1 Global Non-invasive Cancer Diagnosis Market Perspective (2015-2026)
• 2.2 Global Non-invasive Cancer Diagnosis Growth Trends by Regions
  • 2.2.1 Non-invasive Cancer Diagnosis Market Size by Regions: 2015 VS 2020 VS 2026
  • 2.2.2 Non-invasive Cancer Diagnosis Historic Market Share by Regions (2015-2020)
  • 2.2.3 Non-invasive Cancer Diagnosis Forecasted Market Size by Regions (2021-2026)
• 2.3 Industry Trends and Growth Strategy
  • 2.3.1 Market Top Trends
  • 2.3.2 Market Drivers
  • 2.3.3 Market Challenges
  • 2.3.4 Porter’s Five Forces Analysis
  • 2.3.5 Non-invasive Cancer Diagnosis Market Growth Strategy
  • 2.3.6 Primary Interviews with Key Non-invasive Cancer Diagnosis Players (Opinion Leaders)

3 Competition Landscape by Key Players

• 3.1 Global Top Non-invasive Cancer Diagnosis Players by Market Size
  • 3.1.1 Global Top Non-invasive Cancer Diagnosis Players by Revenue (2015-2020)
  • 3.1.2 Global Non-invasive Cancer Diagnosis Revenue Market Share by Players (2015-2020)
  • 3.1.3 Global Non-invasive Cancer Diagnosis Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
• 3.2 Global Non-invasive Cancer Diagnosis Market Concentration Ratio
  • 3.2.1 Global Non-invasive Cancer Diagnosis Market Concentration Ratio (CR5 and HHI)
  • 3.2.2 Global Top 10 and Top 5 Companies by Non-invasive Cancer Diagnosis Revenue in 2019
• 3.3 Non-invasive Cancer Diagnosis Key Players Head office and Area Served
• 3.4 Key Players Non-invasive Cancer Diagnosis Product Solution and Service
• 3.5 Date of Enter into Non-invasive Cancer Diagnosis Market
• 3.6 Mergers & Acquisitions, Expansion Plans

4 Market Size by Type (2015-2026)

• 4.1 Global Non-invasive Cancer Diagnosis Historic Market Size by Type (2015-2020)
• 4.2 Global Non-invasive Cancer Diagnosis Forecasted Market Size by Type (2021-2026)

5 Market Size by Application (2015-2026)

• 5.1 Global Non-invasive Cancer Diagnosis Market Size by Application (2015-2020)
• 5.2 Global Non-invasive Cancer Diagnosis Forecasted Market Size by Application (2021-2026)

6 North America

• 6.1 North America Non-invasive Cancer Diagnosis Market Size (2015-2020)
• 6.2 Non-invasive Cancer Diagnosis Key Players in North America (2019-2020)
• 6.3 North America Non-invasive Cancer Diagnosis Market Size by Type (2015-2020)
• 6.4 North America Non-invasive Cancer Diagnosis Market Size by Application (2015-2020)

7 Europe

• 7.1 Europe Non-invasive Cancer Diagnosis Market Size (2015-2020)
• 7.2 Non-invasive Cancer Diagnosis Key Players in Europe (2019-2020)
• 7.3 Europe Non-invasive Cancer Diagnosis Market Size by Type (2015-2020)
• 7.4 Europe Non-invasive Cancer Diagnosis Market Size by Application (2015-2020)

8 China

• 8.1 China Non-invasive Cancer Diagnosis Market Size (2015-2020)
• 8.2 Non-invasive Cancer Diagnosis Key Players in China (2019-2020)
• 8.3 China Non-invasive Cancer Diagnosis Market Size by Type (2015-2020)
• 8.4 China Non-invasive Cancer Diagnosis Market Size by Application (2015-2020)

9 Japan

• 9.1 Japan Non-invasive Cancer Diagnosis Market Size (2015-2020)
• 9.2 Non-invasive Cancer Diagnosis Key Players in Japan (2019-2020)
• 9.3 Japan Non-invasive Cancer Diagnosis Market Size by Type (2015-2020)
• 9.4 Japan Non-invasive Cancer Diagnosis Market Size by Application (2015-2020)

10 Southeast Asia

• 10.1 Southeast Asia Non-invasive Cancer Diagnosis Market Size (2015-2020)
• 10.2 Non-invasive Cancer Diagnosis Key Players in Southeast Asia (2019-2020)
• 10.3 Southeast Asia Non-invasive Cancer Diagnosis Market Size by Type (2015-2020)
• 10.4 Southeast Asia Non-invasive Cancer Diagnosis Market Size by Application (2015-2020)

11 India

• 11.1 India Non-invasive Cancer Diagnosis Market Size (2015-2020)
• 11.2 Non-invasive Cancer Diagnosis Key Players in India (2019-2020)
• 11.3 India Non-invasive Cancer Diagnosis Market Size by Type (2015-2020)
• 11.4 India Non-invasive Cancer Diagnosis Market Size by Application (2015-2020)

12 Central & South America

• 12.1 Central & South America Non-invasive Cancer Diagnosis Market Size (2015-2020)
• 12.2 Non-invasive Cancer Diagnosis Key Players in Central & South America (2019-2020)
• 12.3 Central & South America Non-invasive Cancer Diagnosis Market Size by Type (2015-2020)
• 12.4 Central & South America Non-invasive Cancer Diagnosis Market Size by Application (2015-2020)

13 Key Players Profiles

• 13.1 Gen-Probe Inc.
  • 13.1.1 Gen-Probe Inc. Company Details
  • 13.1.2 Gen-Probe Inc. Business Overview
  • 13.1.3 Gen-Probe Inc. Non-invasive Cancer Diagnosis Introduction
  • 13.1.4 Gen-Probe Inc. Revenue in Non-invasive Cancer Diagnosis Business (2015-2020))
  • 13.1.5 Gen-Probe Inc. Recent Development
• 13.2 A&G Pharmaceutical
  • 13.2.1 A&G Pharmaceutical Company Details
  • 13.2.2 A&G Pharmaceutical Business Overview
  • 13.2.3 A&G Pharmaceutical Non-invasive Cancer Diagnosis Introduction
  • 13.2.4 A&G Pharmaceutical Revenue in Non-invasive Cancer Diagnosis Business (2015-2020)
  • 13.2.5 A&G Pharmaceutical Recent Development
• 13.3 Affymetrix Inc.
  • 13.3.1 Affymetrix Inc. Company Details
  • 13.3.2 Affymetrix Inc. Business Overview
  • 13.3.3 Affymetrix Inc. Non-invasive Cancer Diagnosis Introduction
  • 13.3.4 Affymetrix Inc. Revenue in Non-invasive Cancer Diagnosis Business (2015-2020)
  • 13.3.5 Affymetrix Inc. Recent Development
• 13.4 Digene Corporation
  • 13.4.1 Digene Corporation Company Details
  • 13.4.2 Digene Corporation Business Overview
  • 13.4.3 Digene Corporation Non-invasive Cancer Diagnosis Introduction
  • 13.4.4 Digene Corporation Revenue in Non-invasive Cancer Diagnosis Business (2015-2020)
  • 13.4.5 Digene Corporation Recent Development
• 13.5 Quest Diagnostics Inc.
  • 13.5.1 Quest Diagnostics Inc. Company Details
  • 13.5.2 Quest Diagnostics Inc. Business Overview
  • 13.5.3 Quest Diagnostics Inc. Non-invasive Cancer Diagnosis Introduction
  • 13.5.4 Quest Diagnostics Inc. Revenue in Non-invasive Cancer Diagnosis Business (2015-2020)
  • 13.5.5 Quest Diagnostics Inc. Recent Development
• 13.6 BioView Inc.
  • 13.6.1 BioView Inc. Company Details
  • 13.6.2 BioView Inc. Business Overview
  • 13.6.3 BioView Inc. Non-invasive Cancer Diagnosis Introduction
  • 13.6.4 BioView Inc. Revenue in Non-invasive Cancer Diagnosis Business (2015-2020)
  • 13.6.5 BioView Inc. Recent Development
• 13.7 LabCorp
  • 13.7.1 LabCorp Company Details
  • 13.7.2 LabCorp Business Overview
  • 13.7.3 LabCorp Non-invasive Cancer Diagnosis Introduction
  • 13.7.4 LabCorp Revenue in Non-invasive Cancer Diagnosis Business (2015-2020)
  • 13.7.5 LabCorp Recent Development
• 13.8 AVIVA Biosciences Corporation
  • 13.8.1 AVIVA Biosciences Corporation Company Details
  • 13.8.2 AVIVA Biosciences Corporation Business Overview
  • 13.8.3 AVIVA Biosciences Corporation Non-invasive Cancer Diagnosis Introduction
  • 13.8.4 AVIVA Biosciences Corporation Revenue in Non-invasive Cancer Diagnosis Business (2015-2020)
  • 13.8.5 AVIVA Biosciences Corporation Recent Development
• 13.9 Precision Therapeutics
  • 13.9.1 Precision Therapeutics Company Details
  • 13.9.2 Precision Therapeutics Business Overview
  • 13.9.3 Precision Therapeutics Non-invasive Cancer Diagnosis Introduction
  • 13.9.4 Precision Therapeutics Revenue in Non-invasive Cancer Diagnosis Business (2015-2020)
  • 13.9.5 Precision Therapeutics Recent Development

14 Analyst's Viewpoints/Conclusions

15 Appendix

• 15.1 Research Methodology
  • 15.1.1 Methodology/Research Approach
  • 15.1.2 Data Source
• 15.2 Disclaimer